🧪
hypothesis

Thalamic Reticular Nucleus (TRN) GluN2B Hyperexcitability Disrupts AQP4 Polarization

Hypothesis

Thalamic Reticular Nucleus (TRN) GluN2B Hyperexcitability Disrupts AQP4 Polarization

Excessive GluN2B signaling in TRN GABAergic neurons generates pathological delta-frequency oscillations that dysregulate local astrocyte calcium.
🧬 GRIN2B (TRN neurons); AQP4 polarization via SNTA1🩺 neuroscience🎯 Composite 63%💱 $0.57▼10.8%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates 3 support 2 oppose
✓ All Quality Gates Passed
Mechanistic 0.62 (15%) Evidence 0.60 (15%) Novelty 0.72 (12%) Feasibility 0.60 (12%) Impact 0.65 (12%) Druggability 0.60 (10%) Safety 0.68 (8%) Competition 0.70 (6%) Data Avail. 0.58 (5%) Reproducible 0.58 (5%) KG Connect 0.50 (8%) 0.633 composite
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite63%

🧪 Overview

Excessive GluN2B signaling in TRN GABAergic neurons generates pathological delta-frequency oscillations that dysregulate local astrocyte calcium. Sustained astroglial calcium dysregulation via IP3R2 pathways disrupts AQP4 mRNA translation and M1-muscarinic receptor-mediated AQP4 anchor protein expression, mislocalizing AQP4 and reducing perivascular CSF-ISF exchange.

🧬 Mechanism

🔗 Mechanism from KG for GRIN2B (TRN neurons); AQP4 polarization via SNTA1

Auto-built from this analysis's top knowledge-graph edges.

graph TD
    GluN2B["GluN2B"] -->|regulates| thalamic_burst_firing["thalamic burst firing"]
    slow_wave_oscillations["slow-wave oscillations"] -->|enhances| glymphatic_clearance["glymphatic_clearance"]
    tau_pathology["tau_pathology"] -.->|inhibits| glymphatic_clearance_effi["glymphatic clearance efficiency"]
    Trem2["Trem2"] -->|regulates| tau_phagocytosis["tau phagocytosis"]
    TREM2_deficiency["TREM2 deficiency"] -->|associated with| Tau_Clearance["Tau Clearance"]
    Cx3Cl1["Cx3Cl1"] -->|associated with| Cx3Cr1["Cx3Cr1"]
    Cx3Cr1_1["Cx3Cr1"] -->|regulates| tau_phagocytosis_2["tau phagocytosis"]
    Memantine["Memantine"] -->|enhances| CSF_tracer_clearance["CSF tracer clearance"]
    GluN2B_3["GluN2B"] -->|associated with| cortical_slow_wave_oscill["cortical slow-wave oscillations"]
    oxidative_stress["oxidative_stress"] -->|causes| AQP4_oxidation["AQP4 oxidation"]
    GLUTAMATE_EXCITOTOXICITY["GLUTAMATE EXCITOTOXICITY"] -->|enhances| Tau_Secretion["Tau Secretion"]
    sess_SRB_2026_04_28_h_var["sess_SRB-2026-04-28-h-var-e2b5a7e7db_task_9aae8fc5"] -->|causal extracted| processed["processed"]
    style GluN2B fill:#4fc3f7,stroke:#333,color:#000
    style thalamic_burst_firing fill:#4fc3f7,stroke:#333,color:#000
    style slow_wave_oscillations fill:#4fc3f7,stroke:#333,color:#000
    style glymphatic_clearance fill:#81c784,stroke:#333,color:#000
    style tau_pathology fill:#ef5350,stroke:#333,color:#000
    style glymphatic_clearance_effi fill:#4fc3f7,stroke:#333,color:#000
    style Trem2 fill:#4fc3f7,stroke:#333,color:#000
    style tau_phagocytosis fill:#4fc3f7,stroke:#333,color:#000
    style TREM2_deficiency fill:#4fc3f7,stroke:#333,color:#000
    style Tau_Clearance fill:#4fc3f7,stroke:#333,color:#000
    style Cx3Cl1 fill:#4fc3f7,stroke:#333,color:#000
    style Cx3Cr1 fill:#4fc3f7,stroke:#333,color:#000
    style Cx3Cr1_1 fill:#4fc3f7,stroke:#333,color:#000
    style tau_phagocytosis_2 fill:#4fc3f7,stroke:#333,color:#000
    style Memantine fill:#ce93d8,stroke:#333,color:#000
    style CSF_tracer_clearance fill:#ce93d8,stroke:#333,color:#000
    style GluN2B_3 fill:#4fc3f7,stroke:#333,color:#000
    style cortical_slow_wave_oscill fill:#4fc3f7,stroke:#333,color:#000
    style oxidative_stress fill:#4fc3f7,stroke:#333,color:#000
    style AQP4_oxidation fill:#4fc3f7,stroke:#333,color:#000
    style GLUTAMATE_EXCITOTOXICITY fill:#4fc3f7,stroke:#333,color:#000
    style Tau_Secretion fill:#4fc3f7,stroke:#333,color:#000
    style sess_SRB_2026_04_28_h_var fill:#4fc3f7,stroke:#333,color:#000
    style processed fill:#4fc3f7,stroke:#333,color:#000

⚖️ Evidence

⚖️ Evidence Matrix3 supports2 contradicts
Supports
AQP4 polarization requires astrocytic calcium signaling
PMID:23426672
Supports
TRN hyperactivity in early AD correlates with sleep fragmentation
PMID:32398600
Supports
Muscarinic M1 agonism enhances AQP4 polarization
PMID:31163173
Contradicts
TRN involvement in early AD may be secondary to cortical pathology
PMID:N/A
Contradicts
AQP4 polarization mechanisms in vivo remain incompletely characterized
PMID:N/A
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — GRIN2B

🧬 PDB 7EU8 Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for GRIN2B (TRN neurons); AQP4 polarization via SNTA1 →

No DepMap CRISPR Chronos data found for GRIN2B (TRN neurons); AQP4 polarization via SNTA1.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▼ 0.5%
Volatility
Low
0.0020
Events (7d)
2
Price History
▼10.8%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF we pharmacologically antagonize GluN2B (e.g., ifenprodil 10 mg/kg i.p., daily for 14 days) in 9-12 month old APP/PS1 mice with established amyloid deposition, THEN perivascular AQP4 immunostaining Significant restoration of AQP4 polarization ratio (perivascular/parenchymal) from ~0.3 baseline to >0.7— no observation —pending0.65
IF we perform bilateral TRN optogenetic inhibition (ArchT, 532 nm, 30 Hz, 2h during sleep) while simultaneously measuring glymphatic clearance using intrathecal Texas Red-dextran (MW 10 kDa) in IP3R2 Cortex/medulla fluorescence ratio decrease of >50% in IP3R2 cKO vs. controls, indicating impaired glymphatic CSF-ISF exchange— no observation —pending0.55
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF we pharmacologically antagonize GluN2B (e.g., ifenprodil 10 mg/kg i.p., daily for 14 days) in 9-12 month old APP/PS1 mice with established amyloid deposition, THEN perivascular AQP4 immunostaining colocalized with PDGFRB+ astrocyte endfeet will increase by >40% compared to vehicle-treated control
Predicted outcome: Significant restoration of AQP4 polarization ratio (perivascular/parenchymal) from ~0.3 baseline to >0.7
Falsification: AQP4 polarization ratio remains <0.4 after GluN2B antagonism, or polarization is restored equally by systemic vehicle, indicating the effect is non-specific or independent of TRN GluN2B.
pendingconf 55%
IF we perform bilateral TRN optogenetic inhibition (ArchT, 532 nm, 30 Hz, 2h during sleep) while simultaneously measuring glymphatic clearance using intrathecal Texas Red-dextran (MW 10 kDa) in IP3R2 conditional knockout mice, THEN tracer clearance from cortex will be >50% reduced compared to Cre-ne
Predicted outcome: Cortex/medulla fluorescence ratio decrease of >50% in IP3R2 cKO vs. controls, indicating impaired glymphatic CSF-ISF exchange
Falsification: No significant difference in tracer clearance between IP3R2 cKO and controls; or clearance improves in cKO with optogenetic TRN inhibition, indicating IP3R2-independent pathway dominates.
View on SciDEX ↗